Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy

To impact on the development of clinical congestive heart failure as a complication of doxorubicin therapy, left ventricular ejection fraction was monitored with serial resting radionuclide angiocardiography in 1,487 patients with cancer over a seven-year period in both university and community hospital environments

Ronald G. Schwartz


Scholarcy highlights

Need more features? Save interactive summary cards to your Scholarcy Library.